Abeona Therapeutics Inc. reported earnings results for the fourth quarter ended December 31, 2021. For the fourth quarter, the company reported sales was USD 3 million compared to USD 3 million a year ago. Net loss was USD 46.68 million compared to USD 15.83 million a year ago.

Basic loss per share from continuing operations was USD 11.25 compared to USD 4.25 a year ago.